EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Celiac disease and risk of microscopic colitis: A nationwide population‐based matched cohort study

David Bergman iD, Hamed Khalili, Benjamin Lebwohl, Bjorn Roelstraete, Peter H R Green, Jonas F Ludvigsson

United European Gastroenterology Journal · 2023-03 · 11 (2) · 189-201

DOI: 10.1002/ueg2.12374 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 20.03.2023. Verfasst von David Bergman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Celiac Disease, Colitis, Microscopic, Colitis, Lymphocytic, Colitis, Collagenous. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, Karolinska Institutet, Stockholm läns landsting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An association has been reported between celiac disease (CD) and microscopic colitis (MC). However, large, population‐based cohort studies are rare.

Objective

To systematically examine the association between CD and MC in a large, nationwide cohort.

Methods

We conducted a nationwide population‐based matched cohort study in Sweden of 45,138 patients with biopsy‐verified CD (diagnosed in 1990–2016), 223,149 reference individuals, and 51,449 siblings of CD patients. Data on CD and MC were obtained from all ( n = 28) pathology departments in Sweden. Adjusted hazard ratios (aHRs) were calculated using Cox regression.

Results

During follow‐up, 452 CD patients and 197 reference individuals received an MC diagnosis (86.1 vs. 7.5 per 100,000 person‐years). This difference corresponded to an aHR of 11.6 (95% confidence interval [CI] = 9.8–13.8) or eight extra MC cases in 1000 CD patients followed up for 10 years. Although the risk of MC was highest during the first year of follow‐up (aHR 35.2; 95% CI = 20.1–61.6), it remained elevated even after 10 years (aHR 8.1; 95% CI = 6.0–10.9). Examining MC subtypes lymphocytic colitis (LC) and collagenous colitis (CC) separately, the aHR was 12.4 (95% CI = 10.0–15.3) for LC and 10.2 (95% CI = 7.7–13.6) for CC. MC was also more common before CD (adjusted odds ratio [aOR] = 52.7; 95% CI = 31.4–88.4). Compared to siblings, risk estimates decreased but remained elevated (CD and later MC: HR = 6.2; CD and earlier MC: aOR = 7.9).

Conclusion

Our study demonstrated a very strong association of MC with CD with an increased risk of future and previous MC in CD patients. The magnitude of the associations underscores the need to consider the concomitance of these diagnoses in cases in which gastrointestinal symptoms persist or recur despite a gluten‐free diet or conventional MC treatment. The comparatively lower risk estimates in sibling comparisons suggest that shared genetic and early environmental factors may contribute to the association between CD and MC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseColitis, MicroscopicColitis, LymphocyticColitis, CollagenousHumansCohort Studies

Stichwörter der Autor:innen

NSAIDSSSRIsceliac diseasecollagenous colitisepidemiologylymphocytic colitismicroscopic colitisnon-steroidal anti-inflammatory drugsselective serotonin reuptake inhibitorsvillous atrophy

Autor:innen und Institutionen

  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Massachusetts General Hospital, Crohn's and Colitis Center and Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medicine, Celiac Disease Center at Columbia University Medical Center, New York, New York, USA.
  • Departments of Medicine and Surgical Pathology, Columbia University College of Physicians and Surgeons, New York, New York, USA.
  • Department of Pediatrics, Orebro University Hospital, Orebro, Sweden.

ORCID-Profile: David Bergman

Förderung

  • NIA NIH HHS
  • Karolinska Institutet
  • Stockholm läns landsting
  • Mag-TarmFonden, Swedish Gastroenterology Society

Zitieren

APA

Bergman, D., Khalili, H., Lebwohl, B., Roelstraete, B., Green, P. H. R., & Ludvigsson, J. F. (2023). Celiac disease and risk of microscopic colitis: A nationwide population‐based matched cohort study. United European Gastroenterology Journal, 11(2), 189-201. https://doi.org/10.1002/ueg2.12374

Vancouver

Bergman D, Khalili H, Lebwohl B, Roelstraete B, Green PHR, Ludvigsson JF. Celiac disease and risk of microscopic colitis: A nationwide population‐based matched cohort study. United European Gastroenterology Journal. 2023;11(2):189-201. doi:10.1002/ueg2.12374

BibTeX
@article{Bergman2023,
  author = {Bergman, David and Khalili, Hamed and Lebwohl, Benjamin and Roelstraete, Bjorn and Green, Peter H R and Ludvigsson, Jonas F},
  title = {Celiac disease and risk of microscopic colitis: A nationwide population‐based matched cohort study},
  journal = {United European Gastroenterology Journal},
  year = {2023},
  volume = {11},
  number = {2},
  pages = {189--201},
  doi = {10.1002/ueg2.12374}
}
Kostenlos starten →